Clinical Trial
Published on 09 Mar 2023
Evaluating the efficacy of inhaled amikacin as an adjunct to intravenous combination therapy (ceftazidime and amikacin) in pediatric cystic fibrosis pulmonary exacerbation
in Pharmacology of Infectious Diseases
![Evaluating the efficacy of inhaled amikacin as an adjunct to intravenous combination therapy (ceftazidime and amikacin) in pediatric cystic fibrosis pulmonary exacerbation](https://www.frontiersin.org/files/myhome article library/1130374/1130374_Thumb_400.jpg)
- 3,522 views
- 1 citation